Literature DB >> 21857882

Helicobacter pylori Infection and Gastric Adenocarcinoma.

Pelayo Correa1, M Blanca Piazuelo.   

Abstract

Gastric adenocarcinoma is the second leading cause of cancer-related mortality worldwide. Infection with Helicobacter pylori is the strongest recognized risk factor for gastric adenocarcinoma. This bacterial species colonizes the stomach of more than half of the world's population; however, only a very small proportion of infected subjects develop adenocarcinoma. H. pylori causes a chronic gastritis that may last decades, and a multistep precancerous process is recognized for the most frequent histologic type of gastric adenocarcinoma: the intestinal type. The severity and long-term outcome of this infection is modulated by an increasing list of bacterial, host, and environmental factors, which interplay in a complex manner. Identification of individuals at high risk for gastric cancer that may enter a surveillance program and intervention during the precancerous process is the most suitable strategy for decreasing mortality due to this malignancy.

Entities:  

Year:  2011        PMID: 21857882      PMCID: PMC3158605     

Source DB:  PubMed          Journal:  US Gastroenterol Hepatol Rev        ISSN: 1758-3934


  66 in total

1.  The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer.

Authors:  E M El-Omar; M Carrington; W H Chow; K E McColl; J H Bream; H A Young; J Herrera; J Lissowska; C C Yuan; N Rothman; G Lanyon; M Martin; J F Fraumeni; C S Rabkin
Journal:  Nature       Date:  2001-07-05       Impact factor: 49.962

2.  Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy.

Authors:  J G Fox; P Beck; C A Dangler; M T Whary; T C Wang; H N Shi; C Nagler-Anderson
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

3.  Virulence-associated genotypes of Helicobacter pylori: do they explain the African enigma?

Authors:  Luis E Bravo; Leen-Jan van Doom; J Luis Realpe; Pelayo Correa
Journal:  Am J Gastroenterol       Date:  2002-11       Impact factor: 10.864

4.  Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group.

Authors:  J V Joossens; M J Hill; P Elliott; R Stamler; E Lesaffre; A Dyer; R Nichols; H Kesteloot
Journal:  Int J Epidemiol       Date:  1996-06       Impact factor: 7.196

5.  Intracellular, intercellular, and stromal invasion of gastric mucosa, preneoplastic lesions, and cancer by Helicobacter pylori.

Authors:  Vittorio Necchi; Maria Elena Candusso; Francesca Tava; Ombretta Luinetti; Ulderico Ventura; Roberto Fiocca; Vittorio Ricci; Enrico Solcia
Journal:  Gastroenterology       Date:  2007-01-31       Impact factor: 22.682

6.  Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).

Authors:  Carlos A González; Guillem Pera; Antonio Agudo; H Bas Bueno-de-Mesquita; Marco Ceroti; Heiner Boeing; Mandy Schulz; Giuseppe Del Giudice; Mario Plebani; Fátima Carneiro; Franco Berrino; Carlotta Sacerdote; Rosario Tumino; Salvatore Panico; Göran Berglund; Henrik Simán; Göran Hallmans; Roger Stenling; Carmen Martinez; Miren Dorronsoro; Aurelio Barricarte; Carmen Navarro; José R Quiros; Naomi Allen; Timothy J Key; Sheila Bingham; Nicholas E Day; Jakob Linseisen; Gabriele Nagel; Kim Overvad; Majken K Jensen; Anja Olsen; Anne Tjønneland; Frederike L Büchner; Petra H M Peeters; Mattijs E Numans; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Dimitrios Roukos; Antonia Trichopoulou; Theodora Psaltopoulou; Eiliv Lund; Corinne Casagrande; Nadia Slimani; Mazda Jenab; Elio Riboli
Journal:  Int J Cancer       Date:  2006-05-15       Impact factor: 7.396

Review 7.  Helicobacter pylori VacA, a paradigm for toxin multifunctionality.

Authors:  Timothy L Cover; Steven R Blanke
Journal:  Nat Rev Microbiol       Date:  2005-04       Impact factor: 60.633

Review 8.  Helicobacter pylori and gastric carcinogenesis.

Authors:  Masanori Hatakeyama
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

9.  Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy.

Authors:  Henry T Lynch; Pardeep Kaurah; Debrah Wirtzfeld; Wendy S Rubinstein; Scott Weissman; Jane F Lynch; William Grady; Sara Wiyrick; Janine Senz; David G Huntsman
Journal:  Cancer       Date:  2008-06-15       Impact factor: 6.860

10.  Infection with CagA+ Helicobacter pylori strains as a possible predictor of risk in the development of gastric adenocarcinoma in Mexico.

Authors:  J Torres; G I Pérez-Pérez; Y Leal-Herrera; O Muñoz
Journal:  Int J Cancer       Date:  1998-10-29       Impact factor: 7.396

View more
  65 in total

1.  Integrated Analysis of Mouse and Human Gastric Neoplasms Identifies Conserved microRNA Networks in Gastric Carcinogenesis.

Authors:  Zheng Chen; Zheng Li; Mohammed Soutto; Weizhi Wang; M Blanca Piazuelo; Shoumin Zhu; Yan Guo; Maria J Maturana; Alejandro H Corvalan; Xi Chen; Zekuan Xu; Wael M El-Rifai
Journal:  Gastroenterology       Date:  2018-11-28       Impact factor: 22.682

2.  Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer.

Authors:  A C West; K Tang; H Tye; L Yu; N Deng; M Najdovska; S J Lin; J J Balic; E Okochi-Takada; P McGuirk; B Keogh; W McCormack; P S Bhathal; M Reilly; M Oshima; T Ushijima; P Tan; B J Jenkins
Journal:  Oncogene       Date:  2017-05-08       Impact factor: 9.867

3.  Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups.

Authors:  Wen-Qing Li; Jun-Ling Ma; Lian Zhang; Linda M Brown; Ji-You Li; Lin Shen; Kai-Feng Pan; Wei-Dong Liu; Yuanreng Hu; Zhong-Xiang Han; Susan Crystal-Mansour; David Pee; William J Blot; Joseph F Fraumeni; Wei-Cheng You; Mitchell H Gail
Journal:  J Natl Cancer Inst       Date:  2014-06-12       Impact factor: 13.506

4.  Treatment of synchronous adenocarcinoma and lymphoma of the stomach: A case report.

Authors:  Chien-Hsiang Weng; Ren-Ching Wang; Cheng-Chung Wu; Tseng-Hsi Lin
Journal:  Mol Clin Oncol       Date:  2016-10-05

5.  Decursin inhibits tumor growth, migration, and invasion in gastric cancer by down-regulating CXCR7 expression.

Authors:  Solbi Kim; Ji-Eun Kim; Nayoung Kim; Mina Joo; Myung-Won Lee; Heung Jin Jeon; Hyewon Ryu; Ik-Chan Song; Gyu-Yong Song; Hyo Jin Lee
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

Review 6.  How to stomach an epigenetic insult: the gastric cancer epigenome.

Authors:  Nisha Padmanabhan; Toshikazu Ushijima; Patrick Tan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-17       Impact factor: 46.802

7.  Transgenic expression of interferon-γ in mouse stomach leads to inflammation, metaplasia, and dysplasia.

Authors:  Li-Jyun Syu; Mohamad El-Zaatari; Kathryn A Eaton; Zhiping Liu; Manas Tetarbe; Theresa M Keeley; Joanna Pero; Jennifer Ferris; Dawn Wilbert; Ashley Kaatz; Xinlei Zheng; Xiotan Qiao; Marina Grachtchouk; Deborah L Gumucio; Juanita L Merchant; Linda C Samuelson; Andrzej A Dlugosz
Journal:  Am J Pathol       Date:  2012-10-01       Impact factor: 4.307

Review 8.  Diabetes and gastric cancer: the potential links.

Authors:  Chin-Hsiao Tseng; Farn-Hsuan Tseng
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

9.  The rOmp22-HpaA fusion protein confers protective immunity against helicobacter pylori in mice.

Authors:  Xueyong Huang; Bianli Xu; Guangcai Duan; Chunhua Song
Journal:  Curr Microbiol       Date:  2013-05-30       Impact factor: 2.188

10.  Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males.

Authors:  M Song; M C Camargo; S J Weinstein; G Murphy; N D Freedman; J Koshiol; R Z Stolzenberg-Solomon; C C Abnet; S Männistö; D Albanes; C S Rabkin
Journal:  Aliment Pharmacol Ther       Date:  2017-12-15       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.